BioGaia Investor Relations Material
Latest events
Q1 2025
BioGaia
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BioGaia
Access all reports
BioGaia AB develops and markets a wide range of probiotic products with documented health benefits. The company is focused on human health, animal health and the environment, and creates new benefits through the development of novel target groups and or applications. The company's current product portfolio includes Dysbiosis Treatment, Concept 2, Gastrointestinal Fortifier, Protectis, Nestum, Synbiome Defense, and Vi-sualize. Its products are used in various applications such as food supplement industry, animal health sector and human health sector.
Key slides for BioGaia
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
BIOG
Country
🇸🇪 Sweden